MktsMarkets

Astrana Health Inc.
NASDAQ: ASTHKey statistics
ASTH News
Stories mentioning ASTH from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 965,100 | 950,523 | 956,048 | 654,808 | 620,390 | 665,209 | 478,710 | 486,265 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | ||||||||
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | 28,528 | 18,392 | 19,210 | 20,340 | 20,583 | 720.00 | 28,425 | 30,066 |
| Interest Income | 3,816 | 3,987 | 3,522 | 2,336 | 2,312 | 3,221 | 3,778 | 3,513 |
| Interest Expense | 8,587 | |||||||
| Other Expense | 662.00 | 703.00 | 445.00 | 1,136 | (5,072) | 353.00 | 2,673 | 6,126 |
| Pretax Income | 19,709 | 7,506 | 5,671 | 16,825 | 9,604 | (1,895) | 26,812 | 31,897 |
| Tax Provision | 6,578 | 944.00 | 4,594 | 6,609 | 3,383 | 5,882 | 7,831 | 10,031 |
| Net Income (Loss) | 14,436 | 5,999 | 373.00 | 9,423 | 6,692 | (6,951) | 16,094 | 19,171 |
| Earnings Per Share (Basic) | 0.30 | 0.12 | 0.01 | 0.19 | 0.14 | (0.15) | 0.34 | 0.40 |
| Earnings Per Share (Diluted) | 0.29 | 0.12 | 0.01 | 0.19 | 0.14 | (0.14) | 0.33 | 0.40 |
| Weighted Average Shares Outstanding (Basic) | 48,854 | 49,076 | 49,217 | 49,188 | 48,471 | 47,597 | 47,687 | 47,615 |
| Weighted Average Shares Outstanding (Diluted) | 49,054 | 49,370 | 49,473 | 49,471 | 48,851 | 47,974 | 48,224 | 47,978 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About ASTH
Astrana Health Inc. (NASDAQ: ASTH) is a stock listed on the Nasdaq Stock Market under the ticker symbol ASTH. It last traded at $36.53 (Oct 30, 2026, 4:00 PM ET), down 0.3% on the day. That gives Astrana Health a market capitalisation of $1.8B and a price-to-earnings ratio of 44.1.
Over the past 52 weeks ASTH has traded between $18.08 and $51.60.
Revenue for the quarter ended Mar 31, 2026 was $965.1M; net income $14.4M. Revenue was up 55.6% from $620.4M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $965.1M | $14.4M | 1.5% |
| Dec 31, 2025 | $950.5M | $6.0M | 0.6% |
| Sep 30, 2025 | $956.0M | $373.0K | 0.0% |
| Jun 30, 2025 | $654.8M | $9.4M | 1.4% |
From Astrana Health’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…